Novartis defeats challenge to validity of Afinitor patent

101

Novartis scored a win in litigation over one of the patents underlying its cancer treatment Afinitor, as a federal appeals court on Monday rejected arguments by the would-be maker of a generic version that the patent is invalid.

http://feeds.reuters.com/~r/reuters/healthNews/~3/TZfU065BmJk/novartis-defeats-challenge-to-validity-of-afinitor-patent-idUSKCN1SL059

- Advertisement -